MARGIE BAUMAN: Open Payments
NPI 1235213182 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 27 payments from 9 companies in 2025. Trend: 2023 $639 · 2024 $1,028 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $293 |
| GlaxoSmithKline, LLC. | 7 | $221 |
| Phathom Pharmaceuticals, Inc. | 4 | $189 |
| AERIN MEDICAL INC. | 1 | $181 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Stryker Corporation | 1 | $27 |
| Hikma Pharmaceuticals USA | 1 | $17 |
Products named: DUPIXENT, NUCALA, VOQUEZNA, VIVAER STYLUS, TZIELD, INSPIRE, CORE, Ryaltris.
Industry payments across OK — which companies pay providers there.
